These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

439 related items for PubMed ID: 20654154

  • 21. Clinical Significance of BCL2, C-MYC, and BCL6 Genetic Abnormalities, Epstein-Barr Virus Infection, CD5 Protein Expression, Germinal Center B Cell/Non-Germinal Center B-Cell Subtypes, Co-expression of MYC/BCL2 Proteins and Co-expression of MYC/BCL2/BCL6 Proteins in Diffuse Large B-Cell Lymphoma: A Clinical and Pathological Correlation Study of 120 Patients.
    Ting CY, Chang KM, Kuan JW, Sathar J, Chew LP, Wong OJ, Yusuf Y, Wong L, Samsudin AT, Pana MNBM, Lee SK, Gopal NSR, Puri R, Ong TC, Bahari SK, Goh AS, Teoh CS.
    Int J Med Sci; 2019; 16(4):556-566. PubMed ID: 31171907
    [Abstract] [Full Text] [Related]

  • 22. [Analysis of the immunohistochemical subtypes and prognosis of primary diffuse large B cell lymphoma of the central nervous system].
    Min M, Lin L, Bi CF, Wang XQ, Luo TY, Zhao S, Zhang WY, Liu WP.
    Zhonghua Zhong Liu Za Zhi; 2012 Feb; 34(2):110-6. PubMed ID: 22780928
    [Abstract] [Full Text] [Related]

  • 23. BCL2 translocation defines a unique tumor subset within the germinal center B-cell-like diffuse large B-cell lymphoma.
    Iqbal J, Sanger WG, Horsman DE, Rosenwald A, Pickering DL, Dave B, Dave S, Xiao L, Cao K, Zhu Q, Sherman S, Hans CP, Weisenburger DD, Greiner TC, Gascoyne RD, Ott G, Müller-Hermelink HK, Delabie J, Braziel RM, Jaffe ES, Campo E, Lynch JC, Connors JM, Vose JM, Armitage JO, Grogan TM, Staudt LM, Chan WC.
    Am J Pathol; 2004 Jul; 165(1):159-66. PubMed ID: 15215171
    [Abstract] [Full Text] [Related]

  • 24. [Correlation of BCL-6, MYC and p53 gene abnormalities with immunological subtypes and prognosis of diffuse large B-cell lymphoma].
    Sun GX, Cao XS, Li Q, Wang ZL.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Oct; 29(5):576-81. PubMed ID: 23042398
    [Abstract] [Full Text] [Related]

  • 25. Primary diffuse large B-cell lymphoma of the oral cavity: germinal center classification.
    Bhattacharyya I, Chehal HK, Cohen DM, Al-Quran SZ.
    Head Neck Pathol; 2010 Sep; 4(3):181-91. PubMed ID: 20533006
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [Expression of CD68, cyclin D1 and rearrangement of bcl-6 gene are adverse prognostic factors in diffuse large B-cell lymphoma].
    Liang X, Wang J, Bai W, Sun R.
    Zhonghua Bing Li Xue Za Zhi; 2015 Aug; 44(8):559-64. PubMed ID: 26705179
    [Abstract] [Full Text] [Related]

  • 28. An immunohistochemical study of diffuse large B-cell lymphoma with molecular subtyping based on Hans algorithm.
    Ananthamurthy A, Murali M.
    Indian J Pathol Microbiol; 2024 Jul 01; 67(3):564-568. PubMed ID: 38394429
    [Abstract] [Full Text] [Related]

  • 29. [Clinical significance of bcl-2 protein expression and classification algorithm in diffuse large B-cell lymphoma].
    Li M, Liu CL, Wang XY, Xue XM, Gao ZF.
    Zhonghua Bing Li Xue Za Zhi; 2012 Dec 01; 41(12):813-7. PubMed ID: 23324229
    [Abstract] [Full Text] [Related]

  • 30. Prognostic impact of germinal center-associated proteins and chromosomal breakpoints in poor-risk diffuse large B-cell lymphoma.
    van Imhoff GW, Boerma EJ, van der Holt B, Schuuring E, Verdonck LF, Kluin-Nelemans HC, Kluin PM.
    J Clin Oncol; 2006 Sep 01; 24(25):4135-42. PubMed ID: 16943530
    [Abstract] [Full Text] [Related]

  • 31. Clinicopathologic significance of immunophenotypic profiles related to germinal center and activation B-cell differentiation in diffuse large B-cell lymphoma from Chinese patients.
    Liu YH, Xu FP, Zhuang HG, Lai KC, Xie D, Luo DL, Li L, Luo XL, Xu J, Zhang MH, Zhang F, Li HM.
    Hum Pathol; 2008 Jun 01; 39(6):875-84. PubMed ID: 18440593
    [Abstract] [Full Text] [Related]

  • 32. CD10, BCL6, and MUM1 expression in diffuse large B-cell lymphoma on FNA samples.
    Cozzolino I, Varone V, Picardi M, Baldi C, Memoli D, Ciancia G, Selleri C, De Rosa G, Vetrani A, Zeppa P.
    Cancer Cytopathol; 2016 Feb 01; 124(2):135-43. PubMed ID: 26414904
    [Abstract] [Full Text] [Related]

  • 33. Germinal center B (GCB) and non-GCB cell-like diffuse large B cell lymphomas have similar outcomes following autologous haematopoietic stem cell transplantation.
    Costa LJ, Feldman AL, Micallef IN, Inwards DJ, Johnston PB, Porrata LF, Ansell SM.
    Br J Haematol; 2008 Jul 01; 142(3):404-12. PubMed ID: 18492096
    [Abstract] [Full Text] [Related]

  • 34. Value of GCET1, HGAL (GCET2), and LMO2 in the Determination of Germinal Center Phenotype in Diffuse Large B-cell Lymphoma.
    Berker N, Yeğen G, Özlük Y, Doğan Ö.
    Turk J Haematol; 2023 Aug 31; 40(3):162-173. PubMed ID: 37519110
    [Abstract] [Full Text] [Related]

  • 35. Evaluation of BCL-6, CD10, CD138 and MUM-1 expression in diffuse large B-cell lymphoma patients: CD138 is a marker of poor prognosis.
    Bodoor K, Matalka I, Hayajneh R, Haddad Y, Gharaibeh W.
    Asian Pac J Cancer Prev; 2012 Aug 31; 13(7):3037-46. PubMed ID: 22994707
    [Abstract] [Full Text] [Related]

  • 36. [Diagnostic and therapeutic values of interphase fluorescence in situ hybridization in B-cell lymphomas: a clinicopathologic analysis of 604 cases].
    Chen M, Yang JL, Zhao S, Liu WP, Li GD, Ye YX, Yan JQ, Zhang WY.
    Zhonghua Bing Li Xue Za Zhi; 2018 Dec 08; 47(12):920-925. PubMed ID: 30522172
    [Abstract] [Full Text] [Related]

  • 37. Absence of cyclin-D2 and Bcl-2 expression within the germinal centre type of diffuse large B-cell lymphoma identifies a very good prognostic subgroup of patients.
    Amen F, Horncastle D, Elderfield K, Banham AH, Bower M, Macdonald D, Kanfer E, Naresh KN.
    Histopathology; 2007 Jul 08; 51(1):70-9. PubMed ID: 17593082
    [Abstract] [Full Text] [Related]

  • 38. Blimp-1 protein and Hans classification on prognosis of diffuse large B-cell lymphoma and their interrelation.
    Song Y, Cao Z, Li L, Zhang HT, Zhang X.
    Chin J Cancer; 2010 Sep 08; 29(9):781-6. PubMed ID: 20800019
    [Abstract] [Full Text] [Related]

  • 39. Cell-of-origin of diffuse large B-cell lymphomas determined by the Lymph2Cx assay: better prognostic indicator than Hans algorithm.
    Yoon N, Ahn S, Yong Yoo H, Jin Kim S, Seog Kim W, Hyeh Ko Y.
    Oncotarget; 2017 Mar 28; 8(13):22014-22022. PubMed ID: 28423544
    [Abstract] [Full Text] [Related]

  • 40. Short-term efficacy of rituximab-CHOP and CHOP regimens on two subtypes of diffuse large B-cell lymphoma.
    Xia Y, Li ZM, Shi YX, Xia ZJ, Jiang WQ, Huang HQ.
    Ai Zheng; 2009 Feb 28; 28(2):146-9. PubMed ID: 19550126
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.